Format

Send to

Choose Destination
Sci Transl Med. 2016 Jul 6;8(346):346fs12. doi: 10.1126/scitranslmed.aaf6282.

Small cell lung cancer: Time to revisit DNA-damaging chemotherapy.

Author information

1
Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. anish.thomas@mail.nih.gov pommier@nih.gov.
2
Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. anish.thomas@mail.nih.gov pommier@nih.gov.

Abstract

Rational use of DNA-damaging chemotherapy, with new combinations to heighten DNA replication stress, could improve outcomes in small cell lung cancer.

PMID:
27384345
DOI:
10.1126/scitranslmed.aaf6282
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center